🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
Reporting early real-world clinical data of consecutive patients on the use...
Status
Unknown
Location
UZLEUVEN
Start Date
2020-12-01
Trial ID
NCT05220085
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-03
Trial ID
NCT03810313
Treatments Being Tested
The purpose of this investigator initiated study is to identify the effects...
Status
Terminated
Location
Vista Klinik
Start Date
2020-07-20
Trial ID
NCT04287348
Treatments Being Tested
The purpose of this extension study was to evaluate the efficacy and safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-16
Trial ID
NCT04597632
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of broluc...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-07-02
Trial ID
NCT03802630
Treatments Being Tested
This clinical study was designed to compare the safety and efficacy of brol...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2018-10-30
Trial ID
NCT03710564
Treatments Being Tested
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-28
Trial ID
NCT02434328
Treatments Being Tested
The purpose of this study was to identify innovative early imaging paramete...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-10-15
Trial ID
NCT04774926
Treatments Being Tested
The purpose of this extension study was to assess the safety and efficacy o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-01-15
Trial ID
NCT03386474
Treatments Being Tested